Science Explorer Interactive view Map
Company · Nuremberg · Germany

Novartis (Germany)

In research, Novartis (Germany) stands highest in Medicine (#4,667 of 17,978 worldwide) and Health Sciences (#6,374 of 20,462 worldwide), over all time.

novartis.deROR OpenAlex
World rank, all time
#13,911
of 42,892
Rank in Germany
#683
of 2,077
Research works
461
▼ 10% vs 2013–17
Citations
10k
21.9 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
36%
world 28%

What is Novartis (Germany) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,667 of 17,978 19.4%312
Health SciencesDomain #6,374 of 20,462 19.2%325

Each strip is that field’s whole ranked pool, with the notch where Novartis (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.20× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 5.43× its world share, 3 worksImmunology and Micro…Neuroscience: 0.53× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.49× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.56× its world share, 0 worksChemistryComputer Science: 0.29× its world share, 1 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 1.11× its world share, 1 worksMathematicsPhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyDentistry: 1.22× its world share, 0 worksDentistryHealth Professions: 0.53× its world share, 1 worksHealth ProfessionsMedicine: 3.42× its world share, 34 worksMedicineDecision Sciences: 0.13× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.56× its world share, 2 worksEconomics, Econometr…Psychology: 0.55× its world share, 1 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.5×. Every wedge is a field page.

Who are the top researchers at Novartis (Germany)?

Ranked on the composite score, Michael Bröker lead among researchers whose main affiliation is Novartis (Germany).

  1. 1 Michael Bröker Germany · #767,094 worldwide 64 citations · 19 works
All ranked researchers at Novartis (Germany)

Which keywords describe research at Novartis (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Treatment, Inflammation, Epidemiology, Cardiovascular Disease Prevention, Breast Cancer, Genetic Variants and Autoantibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 2.4×26 topics
  2. Inflammation4▲ 3.8×16 topics
  3. Treatment4▲ 5.6×14 topics
  4. Clinical Trials3▲ 9.7×10 topics
  5. Cardiovascular Disease Prevention3▲ 62×2 topics
  6. Autoantibodies2▲ 21×6 topics
  7. Breast Cancer2▲ 20×5 topics
  8. Genetic Variants2▲ 28×3 topics
  9. Quality of Life2▲ 3.4×9 topics
  10. Hypercholesterolemia2▲ 107×2 topics
  11. Cholesterol-lowering2▲ 100×1 topic
  12. Diagnosis2▲ 4.8×12 topics
  13. Rheumatoid Arthritis2▲ 47×2 topics
  14. Statins2▲ 61×1 topic
  15. Cardiovascular Disease2▲ 3.6×10 topics
  16. Cognitive Impairment2▲ 14×2 topics
  17. Monoclonal Antibodies2▲ 38×3 topics
  18. Cytokines2▲ 12×4 topics
  19. Cardiovascular Risk2▲ 9.8×4 topics
  20. Diagnostic Criteria2▲ 14×3 topics
  21. Gene Expression2▲ 5.1×5 topics
  22. Immune System2▲ 13×4 topics
  23. Metastatic Breast Cancer2▲ 56×2 topics
  24. SARS-CoV-22▲ 9.4×4 topics
  25. Ankylosing Spondylitis2▲ 108×1 topic
  26. Immunosuppressive Therapy2▲ 16×6 topics
  27. Mutation2▲ 16×3 topics
  28. Pregnancy2▲ 14×3 topics
  29. Spondyloarthritis2▲ 108×1 topic
  30. Biopharmaceuticals1▲ 53×3 topics
  31. CDK4/6 Inhibitors1▲ 109×1 topic
  32. Multiple Sclerosis1▲ 73×1 topic
  33. Neuromyelitis Optica1▲ 73×1 topic
  34. Palbociclib1▲ 109×1 topic
  35. Regulatory T Cells1▲ 23×4 topics
  36. ACE2 Receptor1▲ 9.9×3 topics
  37. Immunogenicity1▲ 60×2 topics
  38. Survival Analysis1▲ 9.3×5 topics
  39. Inflammatory Bowel Disease1▲ 21×2 topics
  40. Teratogenicity1▲ 44×2 topics

Which research topics does Novartis (Germany) publish most on?

By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Spondyloarthritis Studies and Treatments, Advanced Breast Cancer Therapies and Multiple Sclerosis Research Studies.

Lipoproteins and Cardiov…2Lipoproteins and Cardiovascular Health: 2 fractional worksSpondyloarthritis Studie…2Spondyloarthritis Studies and Treatments: 2 fractional worksAdvanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksMultiple Sclerosis Resea…1Multiple Sclerosis Research Studies: 1 fractional worksRheumatoid Arthritis Research and Therapies: 1 fractional worksPregnancy and Medication Impact: 1 fractional worksBreast Cancer Treatment …1Breast Cancer Treatment Studies: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksPsoriasis: Treatment and…1Psoriasis: Treatment and Pathogenesis: 1 fractional worksPharmacovigilance and Ad…1Pharmacovigilance and Adverse Drug Reactions: 1 fractional works
SurgeryRheumatologyPulmonary and Respiratory MedicinePathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lipoproteins and Cardiovascular Health Surgery 2 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 2 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
  5. 5 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  6. 6 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 1 works
  7. 7 Breast Cancer Treatment Studies Cancer Research 1 works
  8. 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  9. 9 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  10. 10 Pharmacovigilance and Adverse Drug Reactions Toxicology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.3%not open63.7%

World: 28% of research is openly available.

with international co-authors38.6%domestic only61.4%

World: 19% is written across borders.

How has Novartis (Germany)'s research output changed?

Output in 2018–2022 was 10% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Nuremberg

All research institutions in Nuremberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.